Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genomic discoveries into advances in personalized clinical care and taking 'from-bench-to-bedside' to market. Gypsy Basin is soon to be offering a cutting-edge test for oral cancer that provides early detection of precancerous cellular changes. By leveraging novel research, our breakthrough technology will have the ability to differentiate between grades of cancer by molecular signature in order to assist clinicians in selecting the most appropriate treatment options for their patients.